Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
Tech investing in 2014: If you're like most Americans, you're being eaten alive by zooming food prices.
Thanks to a three-year drought in California – the state that accounts for between 85% and 99% of most of this country's fresh produce – every trip to the supermarket has turned into a financial flogging for U.S. consumers. In fact, vegetable prices have jumped 50% in the past month alone.
If this bout of supermarket inflation were limited to produce, we could probably live with it.
But it's everything.
Since 2011, Washington tells us that the general level of prices – Beltway-speak for "inflation" – have risen 6.4%. Ground beef is up about 17%, chicken more than 18%, and bacon nearly 23%. The West Coast drought and a really lousy winter in the Midwest have combined to make a bad situation even worse.
Dairy prices are rocketing, too – thanks to growing demand from Asia, and particularly from China. The boom in exports – combined with the fallout from the drought here at home – have tightened the supplies of dairy products and have sent prices skyward. Although U.S. dairy exports have surged 19% by volume, they've zoomed by 31% by value – reaching $6.7 billion, according to the latest reports.
And I'm betting you feel the pinch every time you walk down the dairy aisle at your favorite supermarket.
Today I'm here to help ease that pain. I've found a food-related tech investing opportunity that will put some of that money back into your pocket.
This is a profit play you can feel good about holding: The small-cap firm is a global leader in food and agriculture technology, and its offerings help make sure the food sector's crops, animals, and products are clean, safe, and healthy.
In my book, that's a winning combination…
A "Classic" Investing Strategy
If you've been in the markets for any length of time – and I know that lots of you folks have – you're familiar with the whole pick-and-shovel approach to investing.
With that strategy, you don't buy the companies that make the products in a given sector – you invest in the companies that help those producers make the best products possible.
The strategy got its name back in the California Gold Rush days: The people who made the biggest fortunes were the merchants who sold the picks, shovels, pots, and pans to the "Miner Forty-Niners" – the risk-takers who went out and panned for gold, often with dismal results.
In our search for today's profit play, we embraced pretty much that same philosophy.
We wanted to find a food-related supplier that offered the same sort of "enabling" products and services to food producers.
And here's the tech investing play that we found:
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.
A LOT CAN CHANGE IN FOUR YEARS
To achieve a 2X of today's $41.0 Share stock price in four more years you have to assume nothing breaks (in the stock market) or the economy. That might be expecting a bit much, even for an optimist. Bull markets don't often last 9 years without a big correction. We have not had such a correction in the past 5 years and many pundits maintain we are overdue for one.
Interest rates will probably be higher in 4 years and the likelihood of a bear market fairly high by that time, as well. All stocks will be much priced much cheaper during a down market, rather than during the recent tiny pullbacks we have had in the ongoing, 5 year bull market. Save your money and make a shopping list and wait for the market to come to you. Patience pays often times. Your long term total return will be strongly influenced by your initial purchase price, so avoid overpaying for any stock or investment.